Kinaset Therapeutics
PrivateLast Round
Series B
Jan 10, 2026
Total Funding Raised
$171.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Kinaset Therapeutics is a biopharmaceutical company that develops inhaled therapeutics for serious respiratory diseases, including severe asthma.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kinaset Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Kinaset Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 10, 2026 | ||||
| Series A Extension | Jul 18, 2022 | ||||
| Series A | Nov 30, 2020 |
Key People
Founding team and executive leadership
Kinaset Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series B |
| Sixty Degree Capital | Series B |
| EQT Life Sciences | Series B |
| SV Health Investors | Series A Extension |
| Gimv | Series B, Series A, Series A Extension |
| 5AM Ventures | Series B, Series A Extension, Series A |
| Accomplice | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 12, 2026
Daniela Begolo from EQT Life Sciences joins the board.
- Jan 10, 2026
Peter B. Silverman joins the board, formerly of Forge Life Science Partners.
Kinaset Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kinaset Therapeutics's valuation, stock price, and market status.